Our Recommendations
- Global report on hypertension: the race against a silent killer (2023)
- Diretriz para o tratamento farmacológico da hipertensão arterial em adultos (2021)
- مبادئ توجيهيّة بشأن العلاج الدوائي لفرط ضغط الدم لدى البالغين (2021)
- Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk (2007)
- Guideline for the pharmacological treatment of hypertension in adults (2021)
New Publications
- HEARTS in the Americas: Technical Package (2020)
- Guidelines for Management of ST-Elevated Myocardial Infarction (2022)
- South African cardiovascular risk stratification guideline for non-cardiac surgery (2021)
- National User Guide on the Prevention and Treatment of Hypertension in Adults at the PHC Level 2021 (2021)
- 2018 Prevention Guidelines Tool CV Risk Calculator (2020)
Filter
53
Featured
Recommendations
7
New Publications
16
Language
Document type
No document type
26
Guidelines
11
Fact sheets
5
Manuals
4
Studies & Reports
4
Infographics
2
Strategic & Response Plan
1
Countries / Regions
Latin America and the Carribbean
5
Global
1
West and Central Africa
1
Middle East and North Africa
1
East and Southern Africa
1
South Africa
1
Brazil
1
Ecuador
1
India
1
Bahamas
1
Authors & Publishers
Publication Years
Toolboxes
NCDs
16
COVID-19
5
Mental Health
2
Caregiver
1
HEARTS provides a set of locally adaptable tools for strengthening the
management of CVD in primary health care.
HEARTS is designed to enhance implementation of WHO PEN by providing:
• operational guidance on further integrating CVD management
• technical guidance on evaluating the impact of...
This volume on CVDs, renal, and respiratory disorders has particularly high value. It carries the potential to become the most effective game-changer in global health by helping all countries to combat, contain, and control the biggest killer presently prowling the globe and by enabling us to reach ...
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modul...
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Global Hear, March 2014, Vol. 9 no.1
Global Heart, March 2014, Vol. 9 No.1
Sub-Saharan Africa has the world’s youngest populations. The pattern of cardiovascular disease (CVD) is distinctly different from other regions, with a lower proportion of causes stemming from atherosclerosis, and a younger average age at CVD death. Sub-Sahar...
Lancet 2012; 380: 611–19
Series: Hypertension 3
Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk
recommended
These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people
